Clinical

Dataset Information

0

JAB-21822 Activity in Adult Patients With Advanced Solid Tumors Harboring KRAS G12C Mutation


ABSTRACT: This study is to evaluate the safety and tolerability of JAB-21822 monotherapy and combination therapy in adult participants with advanced solid tumors harboring KRAS G12C mutation.

DISEASE(S): Nsclc,Crc,Phase 1: Advanced Solid Tumors, Relapsed Or Refractory To Standard Therapyphase 2: Non-small Cell Lung Cancer, Metastatic Colorectal Cancer, And Other Solid Tumors,Advanced Solid Tumor,Fase 1: Tumores Sólidos Avanzados, Recidivantes O Refractarios A Terapia Estándarfase 2: Cáncer De Pulmón No Microcítico, Cáncer Colorrectal Metastásico Y Otros Tumores Sólidos,Neoplasms

PROVIDER: 2386408 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

| 2710011 | ecrin-mdr-crc
| 2309880 | ecrin-mdr-crc
| 2726548 | ecrin-mdr-crc
| 2743980 | ecrin-mdr-crc
2020-07-01 | GSE134586 | GEO
| 2272421 | ecrin-mdr-crc
| PRJNA393250 | ENA
| 2401233 | ecrin-mdr-crc
| PRJNA332361 | ENA
| PRJNA332360 | ENA